When to use which molecular prognostic scoring system in the management of patients with MDS?

Overview of attention for article published in Bailliere's Best Practice and Research in Clinical Haematology, October 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 14 X posts from 12 X users, with an upper bound of 39,134 followers.

RT @Dr_AmerZeidan: When to use which molecular prognostic scoring system in the managemen... https://t.co/8saVwY0UZM

RT @Dr_AmerZeidan: When to use which molecular prognostic scoring system in the managemen... https://t.co/8saVwY0UZM

When to use which molecular prognostic scoring system in the management of patients with MDS? - ScienceDirect https://t.co/U4L1TSbQub

RT @Dr_AmerZeidan: When to use which molecular prognostic scoring system in the managemen... https://t.co/8saVwY0UZM

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.